Medtronic completes SPR Therapeutics acquisition

Medtronic completed its acquisition of SPR Therapeutics to expand its neuromodulation portfolio and address the pain management market segment. The acquisition aligns with Medtronic's strategic focus on neuromodulation as a key investment area.